TOKYO -- As the coronavirus pandemic brings Japan's dependence on imported medical supplies to the fore, the government has started working with more than 400 domestic companies to bolster production at home.
Generic drugs is among the most vulnerable fields. Japanese producers import around half of their active ingredients from China, South Korea and elsewhere. But the virus has snarled customs procedures around the world.
